HIGHLIGHTS
- who: Barak Pertzov from the (UNIVERSITY) have published the paper: Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study, in the Journal: (JOURNAL)
- what: The authors aimed to evaluate the humoral response after the BNT162b2 vaccine among idiopathic pulmonary fibrosis (IPF) patients treated with antifibrotic therapy and among non-IPF ILD patients treated with anti-inflammatory therapy. Their antibody u2020 and have contributed equally to this study and are co-first authors u2020 and have contributed equally to this study and are co-last . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.